PPT1 and neoplasm: Antimalarial drugs or CNS drugs target the PPT1 and inhibit the de-palmitoylation of PPT1 enzyme to suppress the mTOR signaling pathway, thus reducing the accumulation of anti-tumor drugs in the lysosome [187].